SRSF9 | OmnibusX

I. Expression across cell types

Name	Number of supported studies	Average coverage
natural killer cell	32 studies	33% ± 12%	Explore
endothelial cell	31 studies	35% ± 15%	Explore
fibroblast	29 studies	37% ± 12%	Explore
B cell	28 studies	32% ± 14%	Explore
pericyte	27 studies	33% ± 11%	Explore
CD8-positive, alpha-beta T cell	26 studies	26% ± 10%	Explore
macrophage	24 studies	29% ± 9%	Explore
T cell	23 studies	27% ± 8%	Explore
conventional dendritic cell	23 studies	38% ± 16%	Explore
smooth muscle cell	21 studies	32% ± 9%	Explore
CD4-positive, alpha-beta T cell	21 studies	25% ± 9%	Explore
epithelial cell	20 studies	41% ± 20%	Explore
classical monocyte	20 studies	35% ± 16%	Explore
basal cell	19 studies	41% ± 21%	Explore
plasmacytoid dendritic cell	17 studies	38% ± 14%	Explore
monocyte	16 studies	32% ± 11%	Explore
plasma cell	16 studies	36% ± 13%	Explore
endothelial cell of lymphatic vessel	16 studies	38% ± 12%	Explore
ciliated cell	16 studies	43% ± 21%	Explore
naive B cell	15 studies	24% ± 7%	Explore
non-classical monocyte	15 studies	37% ± 20%	Explore
connective tissue cell	15 studies	38% ± 16%	Explore
gamma-delta T cell	15 studies	29% ± 15%	Explore
dendritic cell	14 studies	33% ± 20%	Explore
mast cell	14 studies	31% ± 14%	Explore
memory B cell	14 studies	26% ± 5%	Explore
mature NK T cell	12 studies	28% ± 11%	Explore
capillary endothelial cell	12 studies	27% ± 9%	Explore
regulatory T cell	12 studies	26% ± 6%	Explore
CD16-positive, CD56-dim natural killer cell, human	11 studies	33% ± 10%	Explore
CD16-negative, CD56-bright natural killer cell, human	11 studies	29% ± 12%	Explore
myofibroblast cell	11 studies	34% ± 12%	Explore
vein endothelial cell	11 studies	31% ± 10%	Explore
endothelial cell of vascular tree	11 studies	32% ± 10%	Explore
myeloid cell	11 studies	34% ± 19%	Explore
secretory cell	10 studies	44% ± 19%	Explore
naive thymus-derived CD8-positive, alpha-beta T cell	10 studies	26% ± 12%	Explore
endothelial cell of artery	10 studies	30% ± 9%	Explore
plasmablast	9 studies	56% ± 20%	Explore
CD8-positive, alpha-beta memory T cell	9 studies	29% ± 10%	Explore
leukocyte	8 studies	36% ± 13%	Explore
abnormal cell	8 studies	42% ± 17%	Explore
mucosal invariant T cell	8 studies	21% ± 4%	Explore
CD4-positive, alpha-beta memory T cell	7 studies	23% ± 5%	Explore
effector memory CD8-positive, alpha-beta T cell	7 studies	32% ± 13%	Explore
precursor B cell	7 studies	42% ± 14%	Explore
alveolar macrophage	6 studies	22% ± 3%	Explore
type II pneumocyte	6 studies	34% ± 13%	Explore
hematopoietic precursor cell	6 studies	53% ± 24%	Explore
club cell	6 studies	43% ± 14%	Explore
naive thymus-derived CD4-positive, alpha-beta T cell	6 studies	28% ± 8%	Explore
progenitor cell	6 studies	43% ± 16%	Explore
goblet cell	6 studies	32% ± 15%	Explore
mesothelial cell	6 studies	50% ± 14%	Explore
innate lymphoid cell	6 studies	30% ± 6%	Explore
neuron	6 studies	48% ± 24%	Explore
T follicular helper cell	6 studies	23% ± 5%	Explore
ionocyte	5 studies	35% ± 16%	Explore
respiratory goblet cell	5 studies	39% ± 23%	Explore
mononuclear phagocyte	5 studies	46% ± 15%	Explore
kidney loop of Henle epithelial cell	5 studies	27% ± 6%	Explore
IgA plasma cell	5 studies	21% ± 4%	Explore
IgG plasma cell	5 studies	25% ± 4%	Explore
hematopoietic stem cell	5 studies	41% ± 18%	Explore
pro-B cell	5 studies	49% ± 16%	Explore
immature B cell	5 studies	39% ± 17%	Explore
effector memory CD4-positive, alpha-beta T cell	5 studies	29% ± 15%	Explore
oligodendrocyte precursor cell	5 studies	32% ± 16%	Explore
type I pneumocyte	4 studies	31% ± 11%	Explore
exhausted T cell	4 studies	34% ± 15%	Explore
pancreatic A cell	4 studies	45% ± 14%	Explore
type B pancreatic cell	4 studies	33% ± 14%	Explore
effector CD8-positive, alpha-beta T cell	4 studies	30% ± 10%	Explore
epithelial cell of proximal tubule	4 studies	24% ± 6%	Explore
enteroendocrine cell	4 studies	49% ± 13%	Explore
transit amplifying cell	4 studies	29% ± 6%	Explore
astrocyte	4 studies	25% ± 14%	Explore
germinal center B cell	4 studies	44% ± 12%	Explore
luminal hormone-sensing cell of mammary gland	4 studies	51% ± 15%	Explore
glutamatergic neuron	4 studies	34% ± 8%	Explore
megakaryocyte-erythroid progenitor cell	4 studies	58% ± 24%	Explore
erythrocyte	4 studies	34% ± 17%	Explore
T-helper 17 cell	4 studies	24% ± 3%	Explore
deuterosomal cell	3 studies	36% ± 10%	Explore
duct epithelial cell	3 studies	29% ± 6%	Explore
precursor cell	3 studies	52% ± 24%	Explore
squamous epithelial cell	3 studies	35% ± 21%	Explore
glomerular endothelial cell	3 studies	22% ± 2%	Explore
kidney distal convoluted tubule epithelial cell	3 studies	35% ± 4%	Explore
enterocyte	3 studies	23% ± 4%	Explore
intestinal crypt stem cell	3 studies	31% ± 10%	Explore
neural crest cell	3 studies	54% ± 12%	Explore
retinal bipolar neuron	3 studies	32% ± 13%	Explore
retinal ganglion cell	3 studies	55% ± 27%	Explore
extravillous trophoblast	3 studies	76% ± 2%	Explore
placental villous trophoblast	3 studies	76% ± 2%	Explore
lymphocyte	3 studies	43% ± 14%	Explore
megakaryocyte	3 studies	29% ± 11%	Explore
brush cell	3 studies	46% ± 24%	Explore
neuroendocrine cell	3 studies	61% ± 17%	Explore
amacrine cell	3 studies	40% ± 16%	Explore
retina horizontal cell	3 studies	42% ± 19%	Explore
microglial cell	3 studies	29% ± 9%	Explore
serous secreting cell	3 studies	32% ± 0%	Explore
Mueller cell	3 studies	23% ± 4%	Explore
CD4-positive helper T cell	3 studies	29% ± 8%	Explore
myoepithelial cell	3 studies	34% ± 18%	Explore
granulocyte	3 studies	32% ± 11%	Explore
luminal cell of prostate epithelium	3 studies	42% ± 11%	Explore
IgM plasma cell	3 studies	29% ± 14%	Explore
GABAergic neuron	3 studies	28% ± 5%	Explore
neutrophil	3 studies	22% ± 5%	Explore
glial cell	3 studies	39% ± 25%	Explore
group 3 innate lymphoid cell	3 studies	38% ± 13%	Explore
keratinocyte	3 studies	37% ± 9%	Explore
T-helper 1 cell	3 studies	21% ± 4%	Explore
interneuron	3 studies	28% ± 8%	Explore
progenitor cell of mammary luminal epithelium	3 studies	35% ± 11%	Explore

II. Expression across tissues

Name	Number of supported studies	Average coverage
lung	15 studies	39% ± 18%	Explore
peripheral blood	14 studies	30% ± 16%	Explore
intestine	9 studies	33% ± 16%	Explore
brain	8 studies	27% ± 9%	Explore
kidney	7 studies	25% ± 7%	Explore
eye	5 studies	26% ± 9%	Explore
lymph node	5 studies	33% ± 19%	Explore
liver	5 studies	34% ± 16%	Explore
pancreas	4 studies	40% ± 13%	Explore
placenta	4 studies	53% ± 23%	Explore
bone marrow	4 studies	32% ± 13%	Explore
uterus	4 studies	44% ± 18%	Explore
breast	4 studies	37% ± 11%	Explore
prostate	3 studies	37% ± 12%	Explore

Tissue	GTEx Coverage	GTEx Average TPM	GTEx Number of samples	TCGA Coverage	TCGA Average TPM	TCGA Number of samples
lung	100%	2500.35	578 / 578	100%	47.07	1155 / 1155
ovary	100%	2630.77	180 / 180	100%	53.67	430 / 430
stomach	100%	2115.46	359 / 359	100%	45.11	286 / 286
esophagus	100%	2418.28	1444 / 1445	100%	37.46	183 / 183
brain	100%	1705.87	2634 / 2642	100%	41.66	704 / 705
breast	100%	2434.64	459 / 459	99%	42.70	1112 / 1118
pancreas	100%	2168.30	328 / 328	99%	38.38	177 / 178
intestine	100%	2188.71	966 / 966	99%	52.96	523 / 527
bladder	100%	2095.95	21 / 21	99%	53.51	500 / 504
prostate	100%	2406.08	245 / 245	99%	51.67	497 / 502
skin	100%	3444.27	1809 / 1809	99%	42.08	467 / 472
uterus	100%	2065.04	170 / 170	99%	52.64	454 / 459
thymus	100%	2822.65	653 / 653	99%	45.39	597 / 605
kidney	100%	2698.88	89 / 89	98%	31.16	880 / 901
adrenal gland	100%	3793.90	258 / 258	94%	33.56	216 / 230
liver	100%	1509.54	225 / 226	94%	24.16	383 / 406
adipose	100%	2274.23	1204 / 1204	0%	0	0 / 0
lymph node	0%	0	0 / 0	100%	61.50	29 / 29
spleen	100%	3202.28	241 / 241	0%	0	0 / 0
tonsil	0%	0	0 / 0	100%	49.58	45 / 45
ureter	0%	0	0 / 0	100%	22.24	1 / 1
blood vessel	100%	1966.75	1334 / 1335	0%	0	0 / 0
peripheral blood	98%	2898.55	912 / 929	0%	0	0 / 0
eye	0%	0	0 / 0	98%	29.71	78 / 80
heart	95%	913.70	819 / 861	0%	0	0 / 0
muscle	92%	684.80	739 / 803	0%	0	0 / 0
abdomen	0%	0	0 / 0	0%	0	0 / 0
bone marrow	0%	0	0 / 0	0%	0	0 / 0
diaphragm	0%	0	0 / 0	0%	0	0 / 0
gingiva	0%	0	0 / 0	0%	0	0 / 0
nasal cavity	0%	0	0 / 0	0%	0	0 / 0
nasopharynx	0%	0	0 / 0	0%	0	0 / 0
nose	0%	0	0 / 0	0%	0	0 / 0
placenta	0%	0	0 / 0	0%	0	0 / 0
spinal column	0%	0	0 / 0	0%	0	0 / 0

III. Associated gene sets

GO_0043279	Biological process	response to alkaloid
GO_0048025	Biological process	negative regulation of mRNA splicing, via spliceosome
GO_0006376	Biological process	mRNA splice site recognition
GO_0009636	Biological process	response to toxic substance
GO_0006397	Biological process	mRNA processing
GO_0000380	Biological process	alternative mRNA splicing, via spliceosome
GO_0016607	Cellular component	nuclear speck
GO_0005730	Cellular component	nucleolus
GO_0005654	Cellular component	nucleoplasm
GO_0019904	Molecular function	protein domain specific binding
GO_0005515	Molecular function	protein binding
GO_0003723	Molecular function	RNA binding

IV. Literature review

[source]

Gene name	SRSF9
Protein name	Serine and arginine rich splicing factor 9 Serine/arginine-rich splicing factor 9 (Pre-mRNA-splicing factor SRp30C) (Splicing factor, arginine/serine-rich 9)
Synonyms	SRP30C SFRS9
Description	FUNCTION: Plays a role in constitutive splicing and can modulate the selection of alternative splice sites. Represses the splicing of MAPT/Tau exon 10. .
Accessions	A0A9L9PWY3 A0A9L9PY11 ENST00000706468.1 ENST00000603963.1 ENST00000706469.1 ENST00000706465.1 ENST00000706467.1 A0A9L9PWX6 ENST00000550458.1 A0A9L9PXJ2 S4R3G0 A0A9L9PX63 ENST00000706464.1 ENST00000706470.1 A0A9L9PXI1 ENST00000229390.8 H0YIB4 A0A9L9PXJ8 ENST00000706466.1 Q13242

SRSF9 report

I. Expression across cell types

II. Expression across tissues

III. Associated gene sets

IV. Literature review